Running Point Capital Advisors, LLC Abbott Laboratories Transaction History
Running Point Capital Advisors, LLC
- $305 Million
- Q1 2025
A detailed history of Running Point Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Running Point Capital Advisors, LLC holds 3,583 shares of ABT stock, worth $478,617. This represents 0.16% of its overall portfolio holdings.
Number of Shares
3,583
Previous 3,200
11.97%
Holding current value
$478,617
Previous $361,000
31.58%
% of portfolio
0.16%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,541Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.5 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.93 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.78 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $234B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...